maprotiline has been researched along with Leishmaniasis, Visceral in 1 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcântara, LM | 1 |
| Ferreira, TCS | 1 |
| Fontana, V | 1 |
| Chatelain, E | 1 |
| Moraes, CB | 1 |
| Freitas-Junior, LH | 1 |
1 other study available for maprotiline and Leishmaniasis, Visceral
| Article | Year |
|---|---|
A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity.
Topics: Animals; Antiprotozoal Agents; Drug Evaluation, Preclinical; Humans; Leishmania; Leishmaniasis; Leis | 2020 |